Norbert G. Riedel, Director of Eton Pharmaceuticals ETON, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $655.7K. The latest trade was on 04/21.

NR

NR

Norbert G. Riedel

Director

Company

Eton Pharmaceuticals ETON

First filing

23/01/05

Trades

33 trades

Buys / sales

0 / 2

12-month net buying

−$655.7K

Last trade

04/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Jazz PharmaceuticalsJAZZ	Open-market sale	02/27	03/02	3,415 sh	$192.00	$655,680	−32.7%
Jazz PharmaceuticalsJAZZ	Open-market sale	23/08/14	23/08/15	1,241 sh	$138.16	$171,456.56	−8.3%